Bellerophon Therapeutics, Inc.

OTCPK:BLPH Stock Report

Market Cap: US$464.8k

Bellerophon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BLPH?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,002,6508.2%
Institutions1,031,3858.43%
General Public10,198,61383.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 16.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.39%
Lepercq de Neuflize Asset Management LLC
1,026,868US$39.0k0%100.0%
5.26%
Michael Nelson
642,844US$24.4k0%no data
1.61%
Naseem Amin
196,670US$7.5k0%no data
0.5%
Theodore Wang
60,913US$2.3k0%no data
0.28%
Peter Fernandes
34,649US$1.3k0%no data
0.21%
Martin Dekker
25,973US$987.00%no data
0.2%
Parag Shah
24,705US$938.80%no data
0.1%
Nicholas Laccona
12,470US$473.90%no data
0.037%
Dimensional Fund Advisors LP
4,517US$171.70%no data
0.014%
Bobae Kim
1,723US$65.50%no data
0.012%
Mary Cloyd
1,457US$55.40%no data
0.01%
Scott Bruder
1,246US$47.40%no data